| Literature DB >> 33800149 |
Suhair Al-Nimry1, Alaa Abu Dayah1, Inas Hasan1, Rawand Daghmash1.
Abstract
There are several reviews that separately cover different aspects of fish gelatin including its preparation, characteristics, modifications, and applications. Its packaging application in food industry is extensively covered but other applications are not covered or covered alongside with those of collagen. This review is comprehensive, specific to fish gelatin/hydrolysate and cites recent research. It covers cosmetic applications, intrinsic activities, and biomedical applications in wound dressing and wound healing, gene therapy, tissue engineering, implants, and bone substitutes. It also covers its pharmaceutical applications including manufacturing of capsules, coating of microparticles/oils, coating of tablets, stabilization of emulsions and drug delivery (microspheres, nanospheres, scaffolds, microneedles, and hydrogels). The main outcomes are that fish gelatin is immunologically safe, protects from the possibility of transmission of bovine spongiform encephalopathy and foot and mouth diseases, has an economic and environmental benefits, and may be suitable for those that practice religious-based food restrictions, i.e., people of Muslim, Jewish and Hindu faiths. It has unique rheological properties, making it more suitable for certain applications than mammalian gelatins. It can be easily modified to enhance its mechanical properties. However, extensive research is still needed to characterize gelatin hydrolysates, elucidate the Structure Activity Relationship (SAR), and formulate them into dosage forms. Additionally, expansion into cosmetic applications and drug delivery is needed.Entities:
Keywords: biomedical applications; cosmetic applications; extraction; fish gelatin/hydrolysate; pharmaceutical applications; properties; sources
Year: 2021 PMID: 33800149 PMCID: PMC8000627 DOI: 10.3390/md19030145
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Preparation method of gelatin from collagen.
Antihypertensive activity of gelatin hydrolysates obtained by enzymatic treatment from different types of fish.
| Fish Part | Enzymes | Isolated Peptides | IC50 | Reference |
|---|---|---|---|---|
| Alaska pollack skin | Alcalase, pronase E, and collagenase | LGP, GLP, PLG, LPG and PGL | 0.72, 1.62, 4.74, 5.73 and 13.93 mM | [ |
| Nile tilapia skin | Bromelain, papain, trypsin, flavourzyme, alcalase and neutrase | Not determined | Antihypertensive activity: 89–93% | [ |
| Salmon (skin, bone, and residual meat) | Corolase PP and Alcalase 2.4 L in combination with flavourzyme 500 L | FG-C1 * (4 peptides) (Pro-Pro, Gly-Phe, Gly-Pro-Val-Ala and Gly-Gly-Pro-Ala-Gly-Pro-Ala-Val) and 2 free amino acids (Arg and Tyr) | 0.13 and 0.28 mg/mL | [ |
| Nile tilapia gelatin (commercially provided) | Alcalase | DPALATEPDPMPF | Antihypertensive activity: 52% | [ |
| Tilapia skin gelatin | Simulated GI Digestion | VGLPNSR, QAGLSPVR | 80.90, 68.35 μM | [ |
| Skate ( | Alcalase and alcalase/protease | LGPLGHQ, MVGSAPGVL | 4.22 and 3.09 μM | [ |
| Sea cucumber ( | Bromelain and alcalase | Peptide of five main amino acids (Glu, Asp, Pro, Gly and Ala) | 0.0142 mg/ml | [ |
| Jellyfish ( | Alcalase | UF3-B2 * was rich in Gly, Pro, Glu, Ala, and Asp | 0.043 mg/ml | [ |
* FG-C1 & UF3-B2: the peptide hydrolysate fractions with the most activity.
Antioxidant activity of isolated peptides from different fish-derived gelatin.
| Fish Part | Enzymes | Isolated Peptides | Assessment of Activity | Reference |
|---|---|---|---|---|
| Nile tilapia skin | Bromelain, papain, trypsin, flavourzyme, alcalase and neutrase | Not determined | ABTS, lipid peroxidation methods, FRAP, and ferrous ion chelating | [ |
| Salmon (skin, bone, and residual meat) | Corolase PP and Alcalase 2.4 L in combination with flavourzyme 500 L | FG-C1 * (4 peptides (Pro-Pro, Gly-Phe, Gly-Pro-Val-Ala and Gly-Gly-Pro-Ala-Gly-Pro-Ala-Val) and 2 free amino acids (Arg and Tyr) | Corolase hydrolysates more potent (ORAC) activities than intact SG | [ |
| Hoki skin | Trypsin, R-chymotrypsin, and pepsin | His-Gly-Pro-Leu-Gly-Pro-Leu | Linoleic acid peroxidation and the activity was closer to the highly active synthetic antioxidant butylated hydroxytoluene. | [ |
| Amur sturgeon skin | Alcalase or flavourzyme | Oligopeptide; N.D. | Preventing lipid oxidation as evidenced by the lower TBARS formation | [ |
* FG-C1 & UF3-B2: the peptide hydrolysate fractions with the most activity.
Figure 2Different types of fish skin gelatin scaffolds. G: simple gelatin; GC: gelatin + chitosan; GCA: gelatin + calcium acetate; GCCA: gelatin + chitosan + calcium acetate [63].
Figure 3SEM microstructure of different types of gelatin scaffolds. G: simple gelatin; GC: gelatin + chitosan; GCA: gelatin + calcium acetate; GCCA: gelatin + chitosan + calciumacetate. (A1,A2): surface; (B): cross section [63].
Figure 4Coating of drug with fish gelatin by coacervation process.
Figure 51500 µm-long microneedle array formed from fish scale biopolymer at 50 °C [115].
Figure 6Microneedle array formed from fish scale biopolymer-nanocellulose 20 g at 80 °C placed next to a human finger [115].
Figure 7Photos of fish gelatin methacryloyl (GelMA) nanogels, doxorubicin (DOX)-loaded GelMA NGs, and free DOX after centrifugation [128].
Figure 8Transmission electron microscopy images of gelatin methacryloyl nanogels (GelMA NGs). (A) Scale bar = 1 µm; (B) scale bar = 200 nm; (C) scale bar = 100 nm [128].